UBS Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.98M | Sell |
448,549
-320,843
| -42% | -$7.67M | ﹤0.01% | 3356 |
|
|
2025
Q4 | $20.6M | Buy |
769,392
+104,546
| +16% | +$2.5M | ﹤0.01% | 2569 |
|
|
2025
Q3 | $14.2M | Sell |
664,846
-71,377
| -10% | -$1.69M | ﹤0.01% | 2935 |
|
|
2025
Q2 | $15.9M | Sell |
736,223
-320,627
| -30% | -$5.96M | ﹤0.01% | 2621 |
|
|
2025
Q1 | $17.6M | Sell |
1,056,850
-184,425
| -15% | -$3.35M | ﹤0.01% | 2473 |
|
|
2024
Q4 | $22.8M | Buy |
1,241,275
+637,123
| +105% | +$10.3M | 0.01% | 2195 |
|
|
2024
Q3 | $9.29M | Buy |
604,152
+148,601
| +33% | +$2.48M | ﹤0.01% | 2442 |
|
|
2024
Q2 | $7.4M | Buy |
455,551
+111,670
| +32% | +$1.8M | ﹤0.01% | 2491 |
|
|
2024
Q1 | $6.36M | Buy |
343,881
+36,522
| +12% | +$905K | ﹤0.01% | 2716 |
|
|
2023
Q4 | $9.62M | Buy |
307,359
+162,663
| +112% | +$3.88M | ﹤0.01% | 2133 |
|
|
2023
Q3 | $3.02M | Buy |
144,696
+4,995
| +4% | +$136K | ﹤0.01% | 3052 |
|
|
2023
Q2 | $3.35M | Sell |
139,701
-13,490
| -9% | -$300K | ﹤0.01% | 2991 |
|
|
2023
Q1 | $2.88M | Sell |
153,191
-214,128
| -58% | -$4.08M | ﹤0.01% | 3038 |
|
|
2022
Q4 | $5.85M | Buy |
367,319
+316,246
| +619% | +$4.94M | ﹤0.01% | 2347 |
|
|
2022
Q3 | $835K | Buy |
51,073
+17,271
| +51% | +$280K | ﹤0.01% | 3908 |
|
|
2022
Q2 | $477K | Sell |
33,802
-29,631
| -47% | -$553K | ﹤0.01% | 4288 |
|
|
2022
Q1 | $1.54M | Sell |
63,433
-155,475
| -71% | -$3.76M | ﹤0.01% | 3690 |
|
|
2021
Q4 | $5.11M | Buy |
218,908
+1,405
| +0.6% | +$28.3K | ﹤0.01% | 2787 |
|
|
2021
Q3 | $3.61M | Buy |
217,503
+205,648
| +1,735% | +$3.96M | ﹤0.01% | 3017 |
|
|
2021
Q2 | $289K | Sell |
11,855
-15,080
| -56% | -$340K | ﹤0.01% | 5103 |
|
|
2021
Q1 | $695K | Sell |
26,935
-11,726
| -30% | -$516K | ﹤0.01% | 4592 |
|
|
2020
Q4 | $2.07M | Buy |
38,661
+8,283
| +27% | +$411K | ﹤0.01% | 3382 |
|
|
2020
Q3 | $1.25M | Buy |
30,378
+5,951
| +24% | +$257K | ﹤0.01% | 3476 |
|
|
2020
Q2 | $1.18M | Buy |
24,427
+422
| +2% | +$20.3K | ﹤0.01% | 3362 |
|
|
2020
Q1 | $1.01M | Sell |
24,005
-115,667
| -83% | -$4.77M | ﹤0.01% | 3327 |
|
|
2019
Q4 | $5.97M | Buy |
139,672
+20,250
| +17% | +$881K | ﹤0.01% | 2446 |
|
|
2019
Q3 | $4.3M | Buy |
119,422
+60,565
| +103% | +$1.84M | ﹤0.01% | 2532 |
|
|
2019
Q2 | $1.57M | Sell |
58,857
-20,150
| -26% | -$515K | ﹤0.01% | 3364 |
|
|
2019
Q1 | $2.12M | Sell |
79,007
-226,807
| -74% | -$5.3M | ﹤0.01% | 2937 |
|
|
2018
Q4 | $4.95M | Sell |
305,814
-3,860
| -1% | -$75K | ﹤0.01% | 2156 |
|
|
2018
Q3 | $6.43M | Buy |
309,674
+131,931
| +74% | +$2.08M | ﹤0.01% | 2133 |
|
|
2018
Q2 | $2.71M | Sell |
177,743
-261,344
| -60% | -$4.66M | ﹤0.01% | 2878 |
|
|
2018
Q1 | $9.87M | Buy |
439,087
+221,465
| +102% | +$6.13M | 0.01% | 1690 |
|
|
2017
Q4 | $6.55M | Sell |
217,622
-35,213
| -14% | -$1.13M | ﹤0.01% | 2088 |
|
|
2017
Q3 | $9.52M | Buy |
252,835
+7,955
| +3% | +$259K | 0.01% | 1653 |
|
|
2017
Q2 | $6.83M | Buy |
244,880
+165,503
| +209% | +$4.93M | ﹤0.01% | 1863 |
|
|
2017
Q1 | $2.73M | Sell |
79,377
-104,105
| -57% | -$3.67M | ﹤0.01% | 2640 |
|
|
2016
Q4 | $5.29M | Buy |
183,482
+25,472
| +16% | +$674K | ﹤0.01% | 2038 |
|
|
2016
Q3 | $5.03M | Sell |
158,010
-29,577
| -16% | -$1M | ﹤0.01% | 2020 |
|
|
2016
Q2 | $6.09M | Buy |
187,587
+170,485
| +997% | +$5.71M | ﹤0.01% | 1774 |
|
|
2016
Q1 | $479K | Buy |
17,102
+4,158
| +32% | +$90.7K | ﹤0.01% | 3809 |
|
|
2015
Q4 | $461K | Sell |
12,944
-40,084
| -76% | -$1.41M | ﹤0.01% | 4018 |
|
|
2015
Q3 | $1.75M | Buy |
53,028
+35,413
| +201% | +$1.47M | ﹤0.01% | 2862 |
|
|
2015
Q2 | $738K | Buy |
17,615
+2,511
| +17% | +$97.2K | ﹤0.01% | 3802 |
|
|
2015
Q1 | $492K | Sell |
15,104
-23,617
| -61% | -$812K | ﹤0.01% | 4162 |
|
|
2014
Q4 | $1.23M | Buy |
+38,721
| New | +$1.1M | ﹤0.01% | 3399 |
|
Other funds holding ACAD
BBA
VPM
RI
VCM
PAI